Medical Care
Global Prostate Cancer Medicine Market Research Report 2025
- Sep 18, 25
- ID: 507512
- Pages: 72
- Figures: 79
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Medicine.
The Prostate Cancer Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Segment by Type
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Prostate Cancer Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Segment by Type
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 LHRH Antagonists
1.2.3 LHRH Analogs
1.2.4 Antiandrogens
1.2.5 Pipeline Drugs for Hormonal Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2020-2031)
2.2 Global Prostate Cancer Medicine Growth Trends by Region
2.2.1 Global Prostate Cancer Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Medicine Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Medicine Market Dynamics
2.3.1 Prostate Cancer Medicine Industry Trends
2.3.2 Prostate Cancer Medicine Market Drivers
2.3.3 Prostate Cancer Medicine Market Challenges
2.3.4 Prostate Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Revenue
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Medicine Revenue
3.4 Global Prostate Cancer Medicine Market Concentration Ratio
3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2024
3.5 Global Key Players of Prostate Cancer Medicine Head office and Area Served
3.6 Global Key Players of Prostate Cancer Medicine, Product and Application
3.7 Global Key Players of Prostate Cancer Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Medicine Breakdown Data by Type
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Medicine Breakdown Data by Application
5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Medicine Market Size (2020-2031)
6.2 North America Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Medicine Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2020-2031)
7.2 Europe Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Medicine Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Medicine Market Size (2020-2031)
9.2 Latin America Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Medicine Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2020-2025)
11.1.5 AstraZeneca plc Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Details
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Prostate Cancer Medicine Introduction
11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2020-2025)
11.2.5 Active Biotech Recent Development
11.3 Bristol Myers-Squibb
11.3.1 Bristol Myers-Squibb Company Details
11.3.2 Bristol Myers-Squibb Business Overview
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2020-2025)
11.3.5 Bristol Myers-Squibb Recent Development
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2020-2025)
11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2020-2025)
11.6.5 Pfizer Inc. Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Prostate Cancer Medicine Introduction
11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2020-2025)
11.7.5 Bayer AG Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Astellas Pharma Inc.
11.9.1 Astellas Pharma Inc. Company Details
11.9.2 Astellas Pharma Inc. Business Overview
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2020-2025)
11.9.5 Astellas Pharma Inc. Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2020-2025)
11.10.5 Roche Holding AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 LHRH Antagonists
1.2.3 LHRH Analogs
1.2.4 Antiandrogens
1.2.5 Pipeline Drugs for Hormonal Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2020-2031)
2.2 Global Prostate Cancer Medicine Growth Trends by Region
2.2.1 Global Prostate Cancer Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Medicine Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Medicine Market Dynamics
2.3.1 Prostate Cancer Medicine Industry Trends
2.3.2 Prostate Cancer Medicine Market Drivers
2.3.3 Prostate Cancer Medicine Market Challenges
2.3.4 Prostate Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Revenue
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Medicine Revenue
3.4 Global Prostate Cancer Medicine Market Concentration Ratio
3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2024
3.5 Global Key Players of Prostate Cancer Medicine Head office and Area Served
3.6 Global Key Players of Prostate Cancer Medicine, Product and Application
3.7 Global Key Players of Prostate Cancer Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Medicine Breakdown Data by Type
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Medicine Breakdown Data by Application
5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Medicine Market Size (2020-2031)
6.2 North America Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Medicine Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2020-2031)
7.2 Europe Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Medicine Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Medicine Market Size (2020-2031)
9.2 Latin America Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Medicine Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2020-2025)
11.1.5 AstraZeneca plc Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Details
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Prostate Cancer Medicine Introduction
11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2020-2025)
11.2.5 Active Biotech Recent Development
11.3 Bristol Myers-Squibb
11.3.1 Bristol Myers-Squibb Company Details
11.3.2 Bristol Myers-Squibb Business Overview
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2020-2025)
11.3.5 Bristol Myers-Squibb Recent Development
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2020-2025)
11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2020-2025)
11.6.5 Pfizer Inc. Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Prostate Cancer Medicine Introduction
11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2020-2025)
11.7.5 Bayer AG Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Astellas Pharma Inc.
11.9.1 Astellas Pharma Inc. Company Details
11.9.2 Astellas Pharma Inc. Business Overview
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2020-2025)
11.9.5 Astellas Pharma Inc. Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2020-2025)
11.10.5 Roche Holding AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of LHRH Antagonists
Table 3. Key Players of LHRH Analogs
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Pipeline Drugs for Hormonal Therapy
Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Prostate Cancer Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Prostate Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Prostate Cancer Medicine Market Share by Region (2020-2025)
Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Prostate Cancer Medicine Market Share by Region (2026-2031)
Table 12. Prostate Cancer Medicine Market Trends
Table 13. Prostate Cancer Medicine Market Drivers
Table 14. Prostate Cancer Medicine Market Challenges
Table 15. Prostate Cancer Medicine Market Restraints
Table 16. Global Prostate Cancer Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Prostate Cancer Medicine Market Share by Players (2020-2025)
Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2024)
Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Prostate Cancer Medicine, Headquarters and Area Served
Table 22. Global Key Players of Prostate Cancer Medicine, Product and Application
Table 23. Global Key Players of Prostate Cancer Medicine, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2020-2025)
Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2026-2031)
Table 29. Global Prostate Cancer Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2020-2025)
Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2026-2031)
Table 33. North America Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 48. AstraZeneca plc Company Details
Table 49. AstraZeneca plc Business Overview
Table 50. AstraZeneca plc Prostate Cancer Medicine Product
Table 51. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 52. AstraZeneca plc Recent Development
Table 53. Active Biotech Company Details
Table 54. Active Biotech Business Overview
Table 55. Active Biotech Prostate Cancer Medicine Product
Table 56. Active Biotech Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 57. Active Biotech Recent Development
Table 58. Bristol Myers-Squibb Company Details
Table 59. Bristol Myers-Squibb Business Overview
Table 60. Bristol Myers-Squibb Prostate Cancer Medicine Product
Table 61. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 62. Bristol Myers-Squibb Recent Development
Table 63. Teva Pharmaceuticals Industries Ltd. Company Details
Table 64. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 65. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product
Table 66. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 67. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Prostate Cancer Medicine Product
Table 71. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Pfizer Inc. Company Details
Table 74. Pfizer Inc. Business Overview
Table 75. Pfizer Inc. Prostate Cancer Medicine Product
Table 76. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 77. Pfizer Inc. Recent Development
Table 78. Bayer AG Company Details
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Prostate Cancer Medicine Product
Table 81. Bayer AG Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 82. Bayer AG Recent Development
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Prostate Cancer Medicine Product
Table 86. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 87. Abbott Laboratories Recent Development
Table 88. Astellas Pharma Inc. Company Details
Table 89. Astellas Pharma Inc. Business Overview
Table 90. Astellas Pharma Inc. Prostate Cancer Medicine Product
Table 91. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 92. Astellas Pharma Inc. Recent Development
Table 93. Roche Holding AG Company Details
Table 94. Roche Holding AG Business Overview
Table 95. Roche Holding AG Prostate Cancer Medicine Product
Table 96. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 97. Roche Holding AG Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Prostate Cancer Medicine Picture
Figure 2. Global Prostate Cancer Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Cancer Medicine Market Share by Type: 2024 VS 2031
Figure 4. LHRH Antagonists Features
Figure 5. LHRH Analogs Features
Figure 6. Antiandrogens Features
Figure 7. Pipeline Drugs for Hormonal Therapy Features
Figure 8. Global Prostate Cancer Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Prostate Cancer Medicine Market Share by Application: 2024 VS 2031
Figure 10. Age Below 55 Case Studies
Figure 11. Age 55-75 Case Studies
Figure 12. Age Above 75 Case Studies
Figure 13. Prostate Cancer Medicine Report Years Considered
Figure 14. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prostate Cancer Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prostate Cancer Medicine Market Share by Region: 2024 VS 2031
Figure 17. Global Prostate Cancer Medicine Market Share by Players in 2024
Figure 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2024
Figure 20. North America Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 22. United States Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 26. Germany Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2020-2031)
Figure 34. China Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 42. Mexico Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 46. Turkey Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 50. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 51. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 52. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 54. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 55. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 56. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 57. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 58. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of LHRH Antagonists
Table 3. Key Players of LHRH Analogs
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Pipeline Drugs for Hormonal Therapy
Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Prostate Cancer Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Prostate Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Prostate Cancer Medicine Market Share by Region (2020-2025)
Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Prostate Cancer Medicine Market Share by Region (2026-2031)
Table 12. Prostate Cancer Medicine Market Trends
Table 13. Prostate Cancer Medicine Market Drivers
Table 14. Prostate Cancer Medicine Market Challenges
Table 15. Prostate Cancer Medicine Market Restraints
Table 16. Global Prostate Cancer Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Prostate Cancer Medicine Market Share by Players (2020-2025)
Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2024)
Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Prostate Cancer Medicine, Headquarters and Area Served
Table 22. Global Key Players of Prostate Cancer Medicine, Product and Application
Table 23. Global Key Players of Prostate Cancer Medicine, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2020-2025)
Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2026-2031)
Table 29. Global Prostate Cancer Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2020-2025)
Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2026-2031)
Table 33. North America Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 48. AstraZeneca plc Company Details
Table 49. AstraZeneca plc Business Overview
Table 50. AstraZeneca plc Prostate Cancer Medicine Product
Table 51. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 52. AstraZeneca plc Recent Development
Table 53. Active Biotech Company Details
Table 54. Active Biotech Business Overview
Table 55. Active Biotech Prostate Cancer Medicine Product
Table 56. Active Biotech Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 57. Active Biotech Recent Development
Table 58. Bristol Myers-Squibb Company Details
Table 59. Bristol Myers-Squibb Business Overview
Table 60. Bristol Myers-Squibb Prostate Cancer Medicine Product
Table 61. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 62. Bristol Myers-Squibb Recent Development
Table 63. Teva Pharmaceuticals Industries Ltd. Company Details
Table 64. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 65. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product
Table 66. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 67. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Prostate Cancer Medicine Product
Table 71. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Pfizer Inc. Company Details
Table 74. Pfizer Inc. Business Overview
Table 75. Pfizer Inc. Prostate Cancer Medicine Product
Table 76. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 77. Pfizer Inc. Recent Development
Table 78. Bayer AG Company Details
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Prostate Cancer Medicine Product
Table 81. Bayer AG Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 82. Bayer AG Recent Development
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Prostate Cancer Medicine Product
Table 86. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 87. Abbott Laboratories Recent Development
Table 88. Astellas Pharma Inc. Company Details
Table 89. Astellas Pharma Inc. Business Overview
Table 90. Astellas Pharma Inc. Prostate Cancer Medicine Product
Table 91. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 92. Astellas Pharma Inc. Recent Development
Table 93. Roche Holding AG Company Details
Table 94. Roche Holding AG Business Overview
Table 95. Roche Holding AG Prostate Cancer Medicine Product
Table 96. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2020-2025) & (US$ Million)
Table 97. Roche Holding AG Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Prostate Cancer Medicine Picture
Figure 2. Global Prostate Cancer Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Cancer Medicine Market Share by Type: 2024 VS 2031
Figure 4. LHRH Antagonists Features
Figure 5. LHRH Analogs Features
Figure 6. Antiandrogens Features
Figure 7. Pipeline Drugs for Hormonal Therapy Features
Figure 8. Global Prostate Cancer Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Prostate Cancer Medicine Market Share by Application: 2024 VS 2031
Figure 10. Age Below 55 Case Studies
Figure 11. Age 55-75 Case Studies
Figure 12. Age Above 75 Case Studies
Figure 13. Prostate Cancer Medicine Report Years Considered
Figure 14. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prostate Cancer Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prostate Cancer Medicine Market Share by Region: 2024 VS 2031
Figure 17. Global Prostate Cancer Medicine Market Share by Players in 2024
Figure 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2024
Figure 20. North America Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 22. United States Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 26. Germany Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2020-2031)
Figure 34. China Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 42. Mexico Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2020-2031)
Figure 46. Turkey Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prostate Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 50. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 51. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 52. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 54. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 55. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 56. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 57. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 58. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232